The DIRECT-CT trial is designed to test the hypothesis that remote controlled CT scanning combined with real time audio-and video conference (AVC) guided assessment from an experienced hospital stroke team (tele-stroke) at decentralized medical centers (DMC) reduces time to intravenous thrombolytic treatment compared to the standard pathway.
Intravenous thrombolysis (IVT) treatment is an effective treatment of disabling acute ischemic stroke (AIS) and leads to improved functional outcomes if administered within 4.5 hours after symptom onset. Since the treatment effect is highly time dependent, it is recommended to give IVT as soon as possible after symptom onset to patients with AIS without contraindications. A CT examination of the head must be performed prior to IVT to exclude intracranial hemorrhage. If an intracerebral hemorrhage (ICH) is detected rapid blood pressure lowering medication should be initiated. As of today, timely delivery of acute stroke treatment is challenging in several parts of Norway due to sparsely populated areas with long geographical distances between hospitals. Patients living in rural areas are at risk of not receiving timely acute stroke treatment. Due to the time sensitive nature of IVT, a decentralized approach to diagnostics and treatment is compelling. However, a CT scanner and medical expertise on acute stroke diagnostics and treatment is not readily available in pre-hospital settings in Norway. Investigators therefore plan to 1) assess the feasibility of widespread implementation of a model with decentralized stroke diagnostics and treatment in rural areas with a stationary CT combined with audio-and video guided support from an experienced stroke team at the local hospital 2) compare treatment access, time metrics and outcomes for stroke patients in the DMC catchment area to patients from similar rural areas without access to decentralized diagnostics and treatment. The risk for patients is minimized through remote controlled CT scanning administered from the local hospital combined with tele-stroke guided assessment by an experienced stroke team and regular simulation trainings. All treatment, including thrombolytic therapy, and monitoring routines are performed according to the hospitals' standard operating procedures (SOP). The primary objective is to compare time from Emergency Medical Communication (EMC) notification to IVT treatment between AIS patients in the intervention group comprising patients from geographical areas with an established service of prehospital stroke diagnostics and treatment at the DMC to the control group comprising patients from similar geographical areas undergoing diagnostics and treatment at their local hospital as per standard pathway.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
52
The intervention includes admittance to the DMC for initial diagnostic work up and acute treatment (if indicated). Paramedics examine the patient and assess stroke severity by NIHSS and G-FAST scoring overseen by a stroke physician at the local hospital through real time video conference. A remote controlled CT scan of the head is conducted, and the stroke team at the local hospital evaluates results and makes a treatment decision in real-time AVC. If treatment is indicated, this is administered by local personnel at the DMC before initiating transport to the local hospital or the comprehensive stroke center in case of LVO. Patients who are unable to reach the DMC prior to estimated admission time at their local hospital, will be treated at their local hospital as per standard pathway.
Helgelandssykehuset Health Trust
Sandnessjøen, Norway
RECRUITINGUniversity Hospital of North Norway Health Trust
Tromsø, Norway
RECRUITINGTime from EMC notification to initiation IVT treatment
The time from Emergency Medical Communication notification to initiation intravenous thrombolysis treatment in eligible patients
Time frame: Day 0
Time from admittance to initiation of IVT treatment (door-to-needle time)
Time from admittance to initiation of IVT treatment (door-to-needle time) in eligible patients
Time frame: Day 0
Time from admittance to start of blood pressure lowering medication in ICH patients
Time from admittance to start of blood pressure lowering medication in ICH patients patients
Time frame: Day 0
Proportion of AIS patients receiving IVT treatment (y/n)
Proportion of acute ischaemic stroke patients receiving IVT treatment (y/n)
Time frame: Day 0
Proportion of AIS patients receiving EVT treatment (y/n)
Proportion of acute ischaemic stroke patients receiving endovascular treatment
Time frame: Day 0
Proportion of patients achieving early neurological improvement
Early neurological improvement, defined as a reduction of ≥8 points on the NHISS, or NIHSS score of 0-1 at 24 hours (22-36 h) (y/n)
Time frame: Day 1
mRS score at 90 days
functional outcome measured by the modified Rankin Scale score (mRS) at discharge and day 90 (± 2 weeks) • mRS category at day 90 (+/- 2 weeks) * excellent functional outcome (mRS 0-1) at day 90 (+/- 2 weeks) * good functional outcome (mRS 0-2) at day 90 (+/- 2weeks) * poor functional outcome (mRS 5-6) at day 90 (+/- 2 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Month 3
Proportion of patients with symptomatic intracranial hemorrhage (sICH)
Proportion of patients with symptomatic intracranial hemorrhage (sICH) complications defined as intracranial hemorrhage on CT/MRI within 36 hours post IVT causally related to an increase of 4 points or more on the NIHSS (y/n)
Time frame: Day 1
Time from symptom onset to groin puncture time
Time from symptom onset to groin puncture time in patients undergoing thrombectomy
Time frame: Day 0
Transportation mode (ground or air ambulance)
Transportation mode to primary or comprehensive stroke centre
Time frame: Day 0
Mortality
Mortality during hospitalization, 30 days, 90 days and 1 year
Time frame: Year 1
Final diagnosis
The final discharge diagnosis
Time frame: Week 2